CORRESP

 

LOGO

 

140 Scott Drive

Menlo Park, California 94025

Tel: +1.650.328.4600 Fax: +1.650.463.2600

www.lw.com

 

  FIRM / AFFILIATE OFFICES

 

 

 

April 15, 2021

 

Beijing

Boston

Brussels

Century City

Chicago

Dubai

Düsseldorf

Frankfurt

Hamburg

Hong Kong

Houston

London

Los Angeles

Madrid

Milan

 

Moscow

Munich

New York

Orange County

Paris

Riyadh

San Diego

San Francisco

Seoul

Shanghai

Silicon Valley

Singapore

Tokyo

Washington, D.C.

VIA EDGAR AND HAND DELIVERY  

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention: Dillon Hagius and Ada D. Sarmento

 

  Re:

Biomea Fusion, Inc.

      

Registration Statement on Form S-1

      

Publicly filed on March 26, 2021

      

File No. 333-254793

Ladies and Gentlemen:

On behalf of Biomea Fusion, Inc. (the “Company” or “Biomea”), we are hereby filing Amendment No. 2 (“Amendment No. 2”) to the Registration Statement on Form S-1 (“Registration Statement”). The Company previously filed a Registration Statement on Form S-1 on March 26, 2021 and Amendment No. 1 to the Registration Statement on April 12, 2021, in each case, with the U.S. Securities and Exchange Commission (the “Commission”). Amendment No. 2 has been revised to reflect the Company’s responses to the comment letter received on April 15, 2021 from the staff of the Commission (the “Staff”).

For ease of review, we have set forth below each of the numbered comments of your letter in bold type followed by the Company’s responses thereto.


April 15, 2021

Page 2

 

LOGO

 

Registration Statement on Form S-1

Prospectus Summary

Overview, page 1

 

1.

We note that you have revised this section to include an additional table depicting your active discovery programs in response to prior comment 1. Please remove this additional table from the Prospectus Summary. We will not object to a narrative description in the Prospectus Summary that summarizes this table.

Response: The Company acknowledges the Staff’s comment and advises the SEC that it has revised pages 2, 109 and 115 of Amendment No. 2 accordingly.

* * *


April 15, 2021

Page 3

 

LOGO

 

We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (415) 395-8198 or by fax at (650) 463-2600 with any questions or comments regarding this correspondence.

Very truly yours,

/s/ Miles P. Jennings

Miles P. Jennings

of LATHAM & WATKINS LLP

 

 

cc:

Thomas Butler, Biomea Fusion, Inc.

    

Rainer (Ramses) Erdtmann, Biomea Fusion, Inc.

    

Brian Cuneo, Latham & Watkins LLP

    

Charles Kim, Cooley LLP

    

Jonie Kondracki, Cooley LLP